← feed

Is NCT06188325 results overdue?

Yes — results are overdue. Primary completion was 2018-03-26; the FDAAA-801 reporting deadline (2019-03-26) passed 2690 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers

NCT IDNCT06188325 ↗
SponsorSanofi (INDUSTRY)
Public issuerSanofi — SNY (CIK 0001121404) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2018-03-26 (ACTUAL)
Reporting deadline2019-03-26 (completion + 365d)
Days overdue2690
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 e70416784ce15820… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT06188325. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →